Immune checkpoints and liver resection after neoadjuvant chemotherapy including bevacizumab in patients with microsatellite-stable colorectal liver metastases.

Stift, Judith; Graf, Alexandra; Neudert, Barbara; Herac, Merima; Woeran, Katharina; Tamandl, Dietmar; Laengle, Johannes; Schwarz, Christoph; Wrba, Friedrich; Kaczirek, Klaus; Stremitzer, Stefan

Stift, Judith; Graf, Alexandra; Neudert, Barbara; Herac, Merima; Woeran, Katharina; Tamandl, Dietmar; Laengle, Johannes; Schwarz, Christoph; Wrba, Friedrich; Kaczirek, Klaus; Stremitzer, Stefan.

Afiliación

Stift J; Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Graf A; Institute for Medical Statistics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University Vienna, Spitalgasse 23, 1090, Vienna, Austria.
Neudert B; Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Herac M; Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Woeran K; Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Tamandl D; Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Laengle J; Department of Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Schwarz C; Department of Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Wrba F; Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Kaczirek K; Department of Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Stremitzer S; Department of Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address: stefan.stremitzer@meduniwien.ac.at.

HPB (Oxford) ; 24(1): 40-46, 2022 01.

Article en En | MEDLINE | ID: mdl-34158230

Asunto(s)

Neoplasias Colorrectales; Neoplasias Hepáticas; Adulto; Anciano; Anciano de 80 o más Años; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Bevacizumab/efectos adversos; Bevacizumab/uso terapéutico; Neoplasias Colorrectales/genética; Neoplasias Colorrectales/patología; Femenino; Humanos; Neoplasias Hepáticas/tratamiento farmacológico; Neoplasias Hepáticas/genética; Neoplasias Hepáticas/cirugía; Masculino; Repeticiones de Microsatélite; Persona de Mediana Edad; Terapia Neoadyuvante; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: HPB (Oxford) Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google